Annual EBIT
-$26.96 M
+$13.60 M+33.53%
31 December 2023
Summary:
Achieve Life Sciences annual earnings before interest & taxes is currently -$26.96 million, with the most recent change of +$13.60 million (+33.53%) on 31 December 2023. During the last 3 years, it has fallen by -$12.23 million (-83.04%). ACHV annual EBIT is now -1785.13% below its all-time high of $2.10 million.ACHV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$12.15 M
-$4.49 M-58.63%
30 September 2024
Summary:
Achieve Life Sciences quarterly earnings before interest & taxes is currently -$12.15 million, with the most recent change of -$4.49 million (-58.63%) on 30 September 2024. Over the past year, it has dropped by -$5.82 million (-91.97%). ACHV quarterly EBIT is now -193.81% below its all-time high of $12.95 million, reached on 31 December 2016.ACHV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$30.17 M
-$5.82 M-23.89%
30 September 2024
Summary:
Achieve Life Sciences TTM earnings before interest & taxes is currently -$30.17 million, with the most recent change of -$5.82 million (-23.89%) on 30 September 2024. Over the past year, it has increased by +$2.79 million (+8.45%). ACHV TTM EBIT is now -398.83% below its all-time high of $10.10 million, reached on 30 September 2017.ACHV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.5% | -92.0% | +8.4% |
| 3 y3 years | -83.0% | -81.5% | +1.7% |
| 5 y5 years | -110.4% | -226.8% | -77.2% |
ACHV EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -83.0% | +33.5% | -159.0% | +3.6% | -24.6% | +27.8% |
| 5 y | 5 years | -110.4% | +33.5% | -316.2% | +3.6% | -128.6% | +27.8% |
| alltime | all time | -1785.1% | +33.5% | -193.8% | +3.6% | -398.8% | +27.8% |
Achieve Life Sciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.15 M(+58.6%) | -$30.17 M(+23.9%) |
| June 2024 | - | -$7.66 M(+34.8%) | -$24.35 M(+0.5%) |
| Mar 2024 | - | -$5.68 M(+21.2%) | -$24.22 M(-10.2%) |
| Dec 2023 | -$26.96 M(-33.5%) | -$4.69 M(-25.9%) | -$26.96 M(-18.2%) |
| Sept 2023 | - | -$6.33 M(-15.9%) | -$32.96 M(-16.0%) |
| June 2023 | - | -$7.53 M(-10.6%) | -$39.23 M(-6.1%) |
| Mar 2023 | - | -$8.42 M(-21.2%) | -$41.76 M(+3.0%) |
| Dec 2022 | -$40.56 M(+22.3%) | -$10.69 M(-15.2%) | -$40.56 M(+9.5%) |
| Sept 2022 | - | -$12.60 M(+25.2%) | -$37.03 M(+19.0%) |
| June 2022 | - | -$10.06 M(+39.5%) | -$31.12 M(-3.9%) |
| Mar 2022 | - | -$7.22 M(+0.9%) | -$32.37 M(-2.4%) |
| Dec 2021 | -$33.15 M(+125.1%) | -$7.15 M(+6.9%) | -$33.15 M(+8.0%) |
| Sept 2021 | - | -$6.69 M(-40.8%) | -$30.70 M(+10.6%) |
| June 2021 | - | -$11.31 M(+41.4%) | -$27.77 M(+43.3%) |
| Mar 2021 | - | -$8.00 M(+70.2%) | -$19.37 M(+31.5%) |
| Dec 2020 | -$14.73 M(-10.9%) | -$4.70 M(+25.2%) | -$14.73 M(+11.3%) |
| Sept 2020 | - | -$3.75 M(+28.6%) | -$13.24 M(+0.3%) |
| June 2020 | - | -$2.92 M(-13.1%) | -$13.20 M(-5.3%) |
| Mar 2020 | - | -$3.36 M(+4.6%) | -$13.95 M(-15.6%) |
| Dec 2019 | -$16.53 M(+29.0%) | -$3.21 M(-13.7%) | -$16.53 M(-2.9%) |
| Sept 2019 | - | -$3.72 M(+1.5%) | -$17.03 M(+2.5%) |
| June 2019 | - | -$3.66 M(-38.4%) | -$16.61 M(+5.5%) |
| Mar 2019 | - | -$5.94 M(+60.2%) | -$15.74 M(+22.8%) |
| Dec 2018 | -$12.81 M(+93.2%) | -$3.71 M(+12.6%) | -$12.81 M(-0.6%) |
| Sept 2018 | - | -$3.29 M(+17.8%) | -$12.89 M(+7.7%) |
| June 2018 | - | -$2.80 M(-7.2%) | -$11.97 M(+28.3%) |
| Mar 2018 | - | -$3.01 M(-20.3%) | -$9.33 M(+40.6%) |
| Dec 2017 | -$6.63 M(+286.9%) | -$3.78 M(+59.2%) | -$6.63 M(-165.7%) |
| Sept 2017 | - | -$2.38 M(+1432.3%) | $10.10 M(+47.9%) |
| June 2017 | - | -$155.00 K(-51.7%) | $6.83 M(+247.2%) |
| Mar 2017 | - | -$321.00 K(-102.5%) | $1.97 M(-214.7%) |
| Dec 2016 | -$1.71 M(-90.9%) | $12.95 M(-329.3%) | -$1.71 M(-90.6%) |
| Sept 2016 | - | -$5.65 M(+12.6%) | -$18.14 M(+5.6%) |
| June 2016 | - | -$5.01 M(+25.3%) | -$17.19 M(-3.2%) |
| Mar 2016 | - | -$4.00 M(+15.0%) | -$17.76 M(-5.3%) |
| Dec 2015 | -$18.75 M(-36.9%) | -$3.48 M(-25.8%) | -$18.75 M(-15.5%) |
| Sept 2015 | - | -$4.69 M(-16.0%) | -$22.21 M(-10.3%) |
| June 2015 | - | -$5.59 M(+11.8%) | -$24.76 M(-7.6%) |
| Mar 2015 | - | -$5.00 M(-27.9%) | -$26.80 M(-9.9%) |
| Dec 2014 | -$29.73 M(-15.8%) | -$6.93 M(-4.3%) | -$29.73 M(-0.4%) |
| Sept 2014 | - | -$7.24 M(-5.1%) | -$29.84 M(-10.2%) |
| June 2014 | - | -$7.63 M(-3.8%) | -$33.21 M(-5.0%) |
| Mar 2014 | - | -$7.93 M(+12.7%) | -$34.98 M(-1.0%) |
| Dec 2013 | -$35.33 M(+27.8%) | -$7.04 M(-33.7%) | -$35.33 M(-2.4%) |
| Sept 2013 | - | -$10.62 M(+13.0%) | -$36.20 M(+6.9%) |
| June 2013 | - | -$9.40 M(+13.5%) | -$33.87 M(+11.3%) |
| Mar 2013 | - | -$8.28 M(+4.7%) | -$30.42 M(+10.0%) |
| Dec 2012 | -$27.64 M(+24.0%) | -$7.91 M(-4.6%) | -$27.64 M(-0.2%) |
| Sept 2012 | - | -$8.29 M(+39.5%) | -$27.71 M(+17.8%) |
| June 2012 | - | -$5.94 M(+8.0%) | -$23.52 M(+4.2%) |
| Mar 2012 | - | -$5.50 M(-31.0%) | -$22.57 M(+1.2%) |
| Dec 2011 | -$22.29 M(+108.2%) | -$7.97 M(+94.6%) | -$22.29 M(+37.3%) |
| Sept 2011 | - | -$4.10 M(-17.9%) | -$16.23 M(+7.9%) |
| June 2011 | - | -$4.99 M(-4.4%) | -$15.04 M(+16.6%) |
| Mar 2011 | - | -$5.22 M(+172.8%) | -$12.90 M(+20.5%) |
| Dec 2010 | -$10.71 M(-882.1%) | -$1.92 M(-34.2%) | -$10.71 M(-791.7%) |
| Sept 2010 | - | -$2.91 M(+2.0%) | $1.55 M(-24.8%) |
| June 2010 | - | -$2.85 M(-5.8%) | $2.06 M(+541.4%) |
| Mar 2010 | - | -$3.03 M(-129.3%) | $321.00 K(-63.3%) |
| Dec 2009 | $1.37 M | $10.34 M(-531.2%) | $875.00 K(-105.9%) |
| Sept 2009 | - | -$2.40 M(-47.8%) | -$14.71 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | -$4.59 M(+85.4%) | -$14.98 M(+4.1%) |
| Mar 2009 | - | -$2.48 M(-52.8%) | -$14.38 M(-11.6%) |
| Dec 2008 | -$11.11 M(-27.1%) | -$5.25 M(+97.1%) | -$16.28 M(+71.5%) |
| Sept 2008 | - | -$2.66 M(-33.3%) | -$9.49 M(-28.0%) |
| June 2008 | - | -$3.99 M(-8.6%) | -$13.18 M(-16.3%) |
| Mar 2008 | - | -$4.37 M(-384.5%) | -$15.74 M(+3.3%) |
| Dec 2007 | -$15.23 M(-42.0%) | $1.54 M(-124.2%) | -$15.24 M(-37.7%) |
| Sept 2007 | - | -$6.35 M(-3.0%) | -$24.47 M(-3.1%) |
| June 2007 | - | -$6.55 M(+69.6%) | -$25.26 M(+3.8%) |
| Mar 2007 | - | -$3.86 M(-49.8%) | -$24.33 M(-7.5%) |
| Dec 2006 | -$26.29 M(+20.5%) | -$7.70 M(+7.9%) | -$26.29 M(+17.8%) |
| Sept 2006 | - | -$7.14 M(+26.9%) | -$22.32 M(-7.9%) |
| June 2006 | - | -$5.62 M(-3.5%) | -$24.23 M(+6.4%) |
| Mar 2006 | - | -$5.83 M(+55.9%) | -$22.77 M(+4.4%) |
| Dec 2005 | -$21.81 M(+31.6%) | -$3.74 M(-58.7%) | -$21.81 M(-7.3%) |
| Sept 2005 | - | -$9.04 M(+117.1%) | -$23.53 M(+29.4%) |
| June 2005 | - | -$4.16 M(-14.4%) | -$18.18 M(+2.0%) |
| Mar 2005 | - | -$4.87 M(-10.7%) | -$17.83 M(+7.6%) |
| Dec 2004 | -$16.58 M(+55.8%) | -$5.45 M(+47.7%) | -$16.58 M(+20.4%) |
| Sept 2004 | - | -$3.69 M(-3.3%) | -$13.77 M(+9.1%) |
| June 2004 | - | -$3.82 M(+5.6%) | -$12.62 M(+5.9%) |
| Mar 2004 | - | -$3.61 M(+36.5%) | -$11.92 M(+12.0%) |
| Dec 2003 | -$10.64 M(-12.6%) | -$2.65 M(+4.2%) | -$10.64 M(+0.6%) |
| Sept 2003 | - | -$2.54 M(-18.5%) | -$10.58 M(-7.3%) |
| June 2003 | - | -$3.12 M(+33.5%) | -$11.41 M(-4.8%) |
| Mar 2003 | - | -$2.33 M(-9.7%) | -$11.99 M(-1.5%) |
| Dec 2002 | -$12.17 M(-5728.3%) | -$2.59 M(-23.4%) | -$12.17 M(+2.9%) |
| Sept 2002 | - | -$3.37 M(-8.7%) | -$11.83 M(+249.9%) |
| June 2002 | - | -$3.69 M(+46.5%) | -$3.38 M(+120.1%) |
| Mar 2002 | - | -$2.52 M(+12.6%) | -$1.54 M(-810.1%) |
| Dec 2001 | $216.30 K(-103.0%) | -$2.24 M(-144.1%) | $216.30 K(-91.0%) |
| Sept 2001 | - | $5.07 M(-374.3%) | $2.41 M(-148.3%) |
| June 2001 | - | -$1.85 M(+140.5%) | -$5.00 M(-9.6%) |
| Mar 2001 | - | -$769.20 K(+1697.2%) | -$5.53 M(-23.6%) |
| Dec 2000 | -$7.23 M(>+9900.0%) | -$42.80 K(-98.2%) | -$7.23 M(-22.6%) |
| Sept 2000 | - | -$2.33 M(-1.9%) | -$9.34 M(+6546.4%) |
| June 2000 | - | -$2.38 M(-3.9%) | -$140.60 K(-85.4%) |
| Mar 2000 | - | -$2.48 M(+14.9%) | -$961.40 K(-6823.1%) |
| Dec 1999 | -$10.50 K(-99.9%) | -$2.15 M(-131.4%) | $14.30 K(-102.0%) |
| Sept 1999 | - | $6.87 M(-314.7%) | -$712.00 K(-92.7%) |
| June 1999 | - | -$3.20 M(+113.3%) | -$9.78 M(-1.0%) |
| Mar 1999 | - | -$1.50 M(-47.9%) | -$9.88 M(-17.5%) |
| Dec 1998 | -$11.88 M(<-9900.0%) | -$2.88 M(+31.0%) | -$11.98 M(+31.7%) |
| Sept 1998 | - | -$2.20 M(-33.3%) | -$9.10 M(+9.6%) |
| June 1998 | - | -$3.30 M(-8.3%) | -$8.30 M(+72.9%) |
| Mar 1998 | - | -$3.60 M(<-9900.0%) | -$4.80 M(-4900.0%) |
| Dec 1997 | $100.00 K(-93.8%) | $0.00(-100.0%) | $100.00 K(-96.2%) |
| Sept 1997 | - | -$1.40 M(-800.0%) | $2.60 M(-62.9%) |
| June 1997 | - | $200.00 K(-84.6%) | $7.00 M(-9.1%) |
| Mar 1997 | - | $1.30 M(-48.0%) | $7.70 M(+352.9%) |
| Dec 1996 | $1.60 M(-132.0%) | $2.50 M(-16.7%) | $1.70 M(-142.5%) |
| Sept 1996 | - | $3.00 M(+233.3%) | -$4.00 M(-53.5%) |
| June 1996 | - | $900.00 K(-119.1%) | -$8.60 M(+13.2%) |
| Mar 1996 | - | -$4.70 M(+46.9%) | -$7.60 M(+590.9%) |
| Dec 1995 | -$5.00 M(-39.0%) | -$3.20 M(+100.0%) | -$1.10 M(-83.3%) |
| Sept 1995 | - | -$1.60 M(-184.2%) | -$6.60 M(+46.7%) |
| June 1995 | - | $1.90 M(+5.6%) | -$4.50 M(-28.6%) |
| Mar 1995 | - | $1.80 M(-120.7%) | -$6.30 M(-21.3%) |
| Dec 1994 | -$8.20 M | -$8.70 M(-1840.0%) | -$8.00 M(-1242.9%) |
| Sept 1994 | - | $500.00 K(+400.0%) | $700.00 K(+250.0%) |
| June 1994 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1994 | - | $100.00 K | $100.00 K |
FAQ
- What is Achieve Life Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Achieve Life Sciences?
- What is Achieve Life Sciences annual EBIT year-on-year change?
- What is Achieve Life Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly EBIT year-on-year change?
- What is Achieve Life Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Achieve Life Sciences?
- What is Achieve Life Sciences TTM EBIT year-on-year change?
What is Achieve Life Sciences annual earnings before interest & taxes?
The current annual EBIT of ACHV is -$26.96 M
What is the all time high annual EBIT for Achieve Life Sciences?
Achieve Life Sciences all-time high annual earnings before interest & taxes is $2.10 M
What is Achieve Life Sciences annual EBIT year-on-year change?
Over the past year, ACHV annual earnings before interest & taxes has changed by +$13.60 M (+33.53%)
What is Achieve Life Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of ACHV is -$12.15 M
What is the all time high quarterly EBIT for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly earnings before interest & taxes is $12.95 M
What is Achieve Life Sciences quarterly EBIT year-on-year change?
Over the past year, ACHV quarterly earnings before interest & taxes has changed by -$5.82 M (-91.97%)
What is Achieve Life Sciences TTM earnings before interest & taxes?
The current TTM EBIT of ACHV is -$30.17 M
What is the all time high TTM EBIT for Achieve Life Sciences?
Achieve Life Sciences all-time high TTM earnings before interest & taxes is $10.10 M
What is Achieve Life Sciences TTM EBIT year-on-year change?
Over the past year, ACHV TTM earnings before interest & taxes has changed by +$2.79 M (+8.45%)